Background Compare glycated hemoglobin (HbA 1c ) diagnostic tests for prediabetes and
Hispanics have among the highest risks for developing type 2 diabetes, second only to African-Americans. 1 For decades, the diagnosis of diabetes was based on plasma glucose criteria (PGC), with either the fasting plasma glucose (FPG) or the 2-hour value in the oral glucose tolerance test (OGTT). with a threshold of ≥48 mmol/mol (6.5%). 1, 3 The Committee also recognized an intermediate group of patients with increased risk for diabetes, known as prediabetes, as described below.
Diabetes prevalence is increasing worldwide, 4 and it is important to study the diagnostic accuracy of HbA 1c and its relationship with other important metabolic and clinical parameters. Even though some reports propose that HbA 1c is useful as a diagnostic criterion of diabetes, [1] [2] [3] 5, 6 others suggest that its diagnostic usefulness is inferior to standard testing because of a low sensitivity. [7] [8] [9] [10] [11] [12] Given the HbA 1c variability among different racial/ethnic groups, its value as a diagnostic tool for diabetes in high-risk populations has been the source of great debate. 13, 14 The early identification of participants at high risk for diabetes offers the opportunity to develop tools that may prevent or delay the progression of the disease and reduce the complications associated with this chronic condition and its burden to society.
This study assesses the value of HbA 1c as a diagnostic criterion for impaired glucose metabolism and to assess its concordance with the PGC results among a high metabolic risk population. We also describe and compare the metabolic characteristics and risk factors that may differ between participants with altered PGC and/or HbA 1c in the context of other clinical diagnoses associated to cardiovascular and renal function.
| PATIENTS AND METHODS

| Study population
This is a cross-sectional analysis of 1342 participants, free of diagnosed diabetes that were recruited for the San Juan Overweight Adult Longitudinal Study (SOALS). The SOALS is a cohort study designed to evaluate the bidirectional association between prediabetes and periodontal disease. Individuals were recruited from around the San Juan Metropolitan area through press releases, advertisements, flyers, and word of mouth. The eligibility criteria include (1) age between 40 and 65 years and (2) overweight or obese. Most of the exclusion criteria relate to health conditions that could potentially increase the risk of systemic complications from the periodontal exam, which was a key component of SOALS. The exclusion criteria were the following: (1) diagnosis of diabetes mellitus or taking insulin or oral antidiabetic agents prior to the baseline exam, (2) less than 4 natural teeth, (3) metastatic cancer and/or undergoing cancer-related treatment, (4) having braces or orthodontic appliances, (5) pregnancy, (6) physician-diagnosed hypoglycemia, congenital heart murmurs, heart valve disease, congenital heart disease, endocarditis, rheumatic fever, and hemophilia or bleeding disorders, (7) active dialysis treatment, (8) active anticoagulant therapy, (9) prescribed antibiotic prophylaxis prior to surgical or dental procedure, (10) having undergone procedures related to cardiovascular disease, (11) having undergone hip bone or joint replacement surgery, (12) severe health conditions or psychological or physical disabilities, and (13) plans for moving away in the next 3-year period. In addition, for this analysis, we excluded 9 participants who were missing OGTT results. Participants signed informed consents.
| Measurements
Participants were asked to fast for 10 hours prior to their appointment and up to the conclusion of the last blood drawing. Fasting blood was drawn for baseline glucose, insulin, HbA 1c , high-sensitivity C-reactive protein (hs-CRP), and serum lipids levels. Blood glucose was evaluated at 30 minutes, 1 hour, and 2 hours after the consumption of a glucose drink containing 75-gram dextrose.
We calculated the homeostatic model assessment of insulin resistance (HOMA-IR) 15 β-cell function (using the disposition index <first quartile of NG participants). Odds ratios and 95% CIs are presented for adjusted models.
| RESULTS
The sample consisted of 1342 participants (71.8% women and 28.2% men). The mean age of this study population was 50.5 ± 6.8 years with BMI of 33.4 ± 6.2 kg/m 2 and HbA 1c level of 40 ± 7.7 mmol/mol (5.8% ± 0.7%). Using only the PGC to stratify our cohort, we found that 60.6%
were classified as NG, 31.3% had prediabetes, and 8.1% were 
| DISCUSSION
In this high metabolic risk population, we studied 2 different and internationally validated diagnostic tests to identify diabetes and prediabetes. We found that the agreement between the 2 tests was low, which is consistent with previous reports in other populations. 8, [16] [17] [18] Discordance between the HbA 1c and glucose tests is somewhat expected, given the different metabolic processes that are captured by each one. The AUC at 0.62 for impaired glucose suggests that the HbA 1c is not a good test to classify the participants as prediabetics; however, the 0.76 AUC for diabetes shows reasonable validity for this population.
The HbA 1c was first described in the late 1960s as a glycated form of hemoglobin that was elevated in patients with diabetes. 19 It has several advantages to the FPG and OGTT, including greater convenience, evidence to suggest greater preanalytical stability, and less day-to-day perturbations during periods of stress, high-glucose load, and illness, as it reflects average glycemia over several months. 2 Several studies have also shown a strong predictive value of HbA 1c for diabetes complications. 3 Since the lifespan of erythrocytes is constant and erythrocytes are freely permeable to glucose, hemoglobin glycation occurs nonenzymatically at a rate directly proportional to the ambient glucose concentration; hence, HbA 1c provides a glycemic history of the previous 120 days. 13 However, our results show that the HbA 1c has low concordance with glucose criteria. The specificity and sensitivity were low for identifying prediabetes, and for identifying participants with diabetes, it was found to be a specific but insensitive method. These findings are in agreement with those reported by other authors. 8 The
HbA 1c has several limitations for the diagnosis of diabetes; conditions that affect erythrocyte turnover, such as hemolysis or blood loss, hemoglobin variants, structural hemoglobinopathies, or erythropoietin therapy, will affect the test results. The potential magnitude of this problem depends also on the prevalence of hemoglobinopathies, which may vary across different races and ethnicities. Advanced liver disease, kidney disease, and iron deficiency have also been reported to impact HbA 1c test results. 5 In addition, racial and ethnic differences in the relationship between HbA 1c and blood glucose have been described. 13, 14 Factors such as variations in red cell survival, extracellular-intracellular glucose balance, and nonglycemic genetic determinants of hemoglobin glycation have been explored as contributors to these disparities. 13 It has also been reported that the oxidative stress, which has been shown to be higher among overweight and obese participants, 20 might also play an important role during the glycation process of hemoglobin [21] [22] [23] and it may somehow explain the discordance among these tests independently of the glucose concentration environment. 21 Moreover, Li et al found that the agreement between HbA 1c criteria and OGTT can be affected by BMI and it can be significantly improved by shifting the HbA 1c threshold for prediabetes within the obese population. 21 Although oxidative stress biomarkers were not measured in our study and their role during the glycation process of hemoglobin is still uncertain, when we stratified our population by overweight and obese, the percent of agreement among the tests did not change dramatically among the subgroups.
Not surprisingly and similarly to the findings reported by Bianchi et al 8 and Boronat et al, 24 we found that the participants without impairment in glucose metabolism by both criteria had the most favorable cardiometabolic risk profile. In our study, participants with diabetes as per the HbA 1c criterion were found to have a higher BMI, larger waist circumference, and a tendency toward lower HDL compared to those meeting only the PGC, supporting that HbA 1c levels might relate to the metabolic syndrome. 24, 25 Moreover, participants with prediabetes and diabetes based only on the glucose criteria were found to have more insulin resistance (ie, had higher HOMA-IR) than those categorized by HbA 1c only, which could be explained by the muscle insulin resistance that characterizes impaired glucose tolerance as described by Bianchi et al 8 and Abdul-Ghani et al. 26 Interestingly, among diabetic patients, the group diagnosed with both criteria had the highest proportion of males (45%), followed by the group diagnosed with only PGC (39%), and the group with HbA 1c only had 11% males.
In our sample, those diagnosed as diabetic patients by both criteria, the HbA 1c was high (mean = 8.2%, SD = 1.6) suggesting that people with high levels detected from the study had not been diagnosed and a large proportion of this population may have undetected diabetes.
Although a logistic regression analysis showed that individuals with prediabetes and diabetes classified by PGC had a greater probability to have insulin resistance and greater impairment in insulin secretion, it is important to recognize that these calculations are computed from indices derived from the fasting state and OGTT.
However, the more accurate hyperinsulinemic euglycemic clamp tests may not be feasible in large epidemiologic studies. samples were only taken once during the initial visit; thus, no retesting was done for abnormal findings. The cross-sectional data limit our ability to compare the 2 tests with respect to eventual progression; however, the focus of this paper is on diagnosis. 
